Vaccines Virtual Issue
"Despite significant levels of morbidity and mortality that many infectious diseases, both bacterial and viral, still impose, our progress towards developing vaccines against many of these agents has been relatively modest over the past 5-10 years. Recent research, particularly utilising novel strategies and sharing of strategies across infectious agents, however, is starting to show promise... This virtual issue is meant to highlight some of the most advanced, state-of-the-art strategies that are being developed today so that humans (and animals) may in the future continue to benefit from one of the oldest, most effective form of human-made self defense: vaccination against disease."
Read more in Professor Peter Timms' editorial, and in the full collection from Pathogens and Disease below.
Editorial
Peter Timms
DOI: 10.1093/femspd/ftx095
What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine
Shelly Bolotin, Eric T. Harvill, Natasha S. Crowcroft
DOI: 10.1093/femspd/ftv057
Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough
Valérie Bouchez, Nicole Guiso
DOI: 10.1093/femspd/ftv055
Roads to the development of improved pertussis vaccines paved by immunology
Jolanda Brummelman, Mieszko M. Wilk, Wanda G. H. Han, Cécile A.C.M van Els, Kingston H.G. Mills
DOI: 10.1093/femspd/ftv067
Characterization of a multicomponent live, attenuated Shigella flexneri vaccine
BreOnna C. DeLaine, Tao Wu, Christen L. Grassel, Avital Shimanovich, Marcela F. Pasetti, Myron M. Levine, Eileen M. Barry
DOI: 10.1093/femspd/ftw034
Novel approaches to Neisseria meningitidis vaccine design
Myron Christodoulides, John Heckels
DOI: 10.1093/femspd/ftx033
Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies
Farah Deeba, Asimul Islam, Syed Naqui Kazim, Irshad Hussain Naqvi, Shobha Broor, Anwar Ahmed, Shama Parveen
DOI: 10.1093/femspd/ftv119
Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a
Madushini N. Dharmasena, Manuel Osorio, Svetlana Filipova, Christina Marsh, Scott Stibitz, Dennis J. Kopecko
DOI: 10.1093/femspd/ftw098
Towards new TB vaccines: What are the challenges?
Hazel M. Dockrell
DOI: 10.1093/femspd/ftw016
An optimized, fast-to-perform mouse lung infection model with the human pathogen Chlamydia trachomatis for in vivo screening of antibiotics, vaccine candidates and modified host-pathogen interactions
Pavel Dutow, Lea Wask, Miriam Bothe, Beate Fehlhaber, Robert Laudeley, Claudia Rheinheimer, Zhangsheng Yang, Guanming Zhong, Silke Glage, Andreas Klos
DOI: 10.1093/femspd/ftv120
T-cell immune responses to Bordetella pertussis infection and vaccination
Giorgio Fedele, Antonio Cassone, Clara Maria Ausiello
DOI: 10.1093/femspd/ftv051
Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?
Jamie Findlow, Ray Borrow
DOI: 10.1093/femspd/ftx025
SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ
Jamie Findlow, Ray Borrow
DOI: 10.1093/femspd/ftx025
Excavating the surface-associated and secretory proteome of Mycobacterium leprae for identifying vaccines and diagnostic markers relevant immunodominant epitopes
Aarti Rana, Shweta Thakur, Nupur Bhardwaj, Devender Kumar, Yusuf Akhter
DOI: 10.1093/femspd/ftw110
Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice
Sean P. Riley, Marissa M. Cardwell, Yvonne G.Y. Chan, Ludovic Pruneau, Fabio Del Piero, Juan J. Martinez
DOI: 10.1093/femspd/ftv101
Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates
Araceli E. Santiago, Barbara J. Mann, Aiping Qin, Aimee L. Cunningham, Leah E. Cole, Christen Grassel, Stefanie N. Vogel, Myron M. Levine, Eileen M. Barry
DOI: 10.1093/femspd/ftv036
Bordatella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential
Erich V. Scheller, Peggy A. Cotter
DOI: 10.1093/femspd/ftv079
Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB
Jing Yang, Lv-xia Dai, Xing Pan, Hongren Wang, Bei Li, Jie Zhu, Ming-yuan, Xin-li Shi, Bao-ning Wang
DOI: 10.1093/femspd/ftv026